Genfit’s NASH hopes are dashed by phase 3 trial fail

Genfit has seen almost two-thirds of the value wiped off its shares after its much-anticipated pivotal trial of non-alcoholic steatohepatitis (NASH) drug elafibranor turned out

Ferring’s gut microbiome drug clears phase 3 trial in C. dif...

Ferring Pharma has reported what it says is the first positive phase 3 trial of a microbiome therapy – based on healthy bacteria – showing it can reduce recurrences of a seriou

AiCure launches “digital biomarker” app for clinical trials

Artificial intelligence company AiCure has launched a digital tool that detects subtle changes in a patient’s condition that can be used to enrich data generated in clinical tr

Immuno-oncology latecomer GSK shows off PD-1 drug data

Pfizer, BioNTech aim to start German COVID-19 vaccine trial ...

Oxford Uni coronavirus vaccine trial could begin this week